IRCCS Ospedale Galeazzi- Sant’Ambrogio offers specialized Immunotherapy supported by experienced oncology specialists, advanced treatment technology, and structured patient monitoring. Established in 1963, the SSN accredited hospital is situated in milan, Italy and has 560 beds with comprehensive cancer treatment infrastructure.

Immunotherapy may be recommended for selected patients when the cancer has specific characteristics that make it responsive to immune-based treatment. Certain medicines work by removing inhibitory signals that prevent immune cells from attacking cancer, while others target specific immune pathways or cancer-associated proteins. Treatment is usually administered according to a planned schedule, with patients monitored for fatigue, skin reactions, inflammation, and other potential immune-related effects.